secwatch / observer
8-K filed October 30, 2025, 7:59 PM ET ticker MOBX CIK 0001855467
regulatory confidence high sentiment positive materiality 0.80

Mobix Labs gets Nasdaq extension to Apr 2026; reclasses $6.3M warrants to equity

MOBIX LABS, INC

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001493152-25-020249
form_type
8-K
ticker
MOBX
cik
0001855467
company_name
MOBIX LABS, INC
filed_at
2025-10-30T23:59:59+00:00
discovered_at
2026-05-14T18:02:40.833985+00:00
generated_at
2026-05-17T01:24:56.706771+00:00
sec_items
["1.01", "3.01", "8.01", "9.01"]
event_type
regulatory
sentiment
positive
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001493152-25-020249
json_url
https://secwatch.observer/filing/0001493152-25-020249.json
markdown_url
https://secwatch.observer/filing/0001493152-25-020249.md
text_url
https://secwatch.observer/filing/0001493152-25-020249.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1855467/000149315225020249/0001493152-25-020249-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1855467/000149315225020249/form8-k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

78c664839117631f47cc698c3200703934eaecea

MOBIX LABS, INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

SEC 8-K Item 3.01 confidence 0.98 SEC evidence

Comparable filings

RR

Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing

RICHTECH ROBOTICS INC. May 28, 2026, 4:49 PM ET regulatory Items 3.01, 8.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 8.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

May 22, 2026, Richtech Robotics Inc., a Nevada corporation (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), because it has not timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “ Form 10-Q ”) with the U.S. Securities and Exchange Commission (the “ SEC ”). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Com

Filing page SEC filing

SONM

DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider

DNA X, Inc. May 27, 2026, 4:35 PM ET regulatory Items 1.01, 2.03, 3.01, 3.02, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests a hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting

Filing page SEC filing

XHLD

TEN Holdings receives Nasdaq equity deficiency notice; issues 500k shares for $500k

TEN Holdings, Inc. May 26, 2026, 4:05 PM ET regulatory Items 1.01, 3.01, 3.02, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

May 26, 2026, the Company received a deficiency letter from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasda

Filing page SEC filing

LRHC

La Rosa Holdings receives Nasdaq deficiency notice for late 10-K and 10-Q filings

La Rosa Holdings Corp. May 22, 2026, 5:20 PM ET regulatory Items 3.01, 8.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 8.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

May 21, 2026, the Company received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company is delinquent in filing its Form 10-Q and remains delinquent in filin

Filing page SEC filing

SBEV

Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M

SPLASH BEVERAGE GROUP, INC. May 5, 2026, 7:59 PM ET regulatory Items 1.01, 1.02, 3.01, 3.02, 5.03, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

April 29, 2026, the Company received notice from NYSE Regulation (the “NYSE”) that the Company is not in compliance with the shareholders’ equity requirement of $6 million as of December 31, 2025 as outlined in Section 1

Filing page SEC filing

PFSA

Profusa faces Nasdaq delisting for MVPHS failure; amends debt and warrant terms

Profusa, Inc. April 29, 2026, 7:59 PM ET regulatory Items 1.01, 2.03, 3.03, 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

April 28, 2026, the Company received written notification from the Nasdaq Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company had not regained compliance with Na

Filing page SEC filing

MDCX

Medicus Pharma receives Nasdaq bid price deficiency notice; expands ATM to $50M

Medicus Pharma Ltd. April 24, 2026, 7:59 PM ET regulatory Items 1.01, 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

April 21, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that the closing bid price for the Company's

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 9.01 same event type: regulatory similar materiality

This filing

April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requirement”). The notice provided the Company 180 calendar days, or until October 27, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days, as provided in Nasdaq Listing Rule 5810(c)(3)(A) (the “Initial Compl

Comparable filing

May 27, 2026, Actinium Pharmaceuticals, Inc. (the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating that the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31, 2026, the Company reported stockholders’ equity of approximately

Filing page SEC filing

Source: SEC EDGAR
accession 0001493152-25-020249

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.